期刊文献+

纳米生物技术基因治疗载体研究进展 被引量:7

Nanobiotechnological Gene Transfer Vectors in Gene Therapy
下载PDF
导出
摘要 基因治疗已在治疗多种人类重大疾病如遗传病、肿瘤等方面显示出良好的应用前景,但也面临着巨大的挑战,其中之一就是需要安全、高效、靶向的载体系统。纳米生物材料,如脂质体、聚丙交酯-乙交酯(PLGA),聚乳酸(PLA)等,由于具有良好的生物安全性、可方便有效地实现基因靶向性及高效表达和缓释,成为制备高效、靶向的基因治疗载体系统的良好介质,日益在基因治疗载体系统中受到广泛重视。本文综述了目前在基因治疗领域中常用的纳米载体的生物学特性,以及它们的最新研究进展。 Gene therapy has shown great potentials in the treatment of a number of human key diseases, such as genetic diseases, cancer and so on, yet there are still some big challenges to face. One of these challenges is how to develop efficient, safe, targeting and controlled release gene delivery systems. With the progress of nanobiotechnologies, some nanobiomaterlals such as liposome, poly (D, L lactic-co-glycolic acid) and poly (Llactide) have great potencies in developing the ideal gene transfer vector, just because of their properties of biocompatibility, bio-degradation, controllable release, easy modification for targeting and so on. In this review is presented a summary of the excellent properties of the nanobiotechnological gene delivery systems and their recent encouraging advances.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2005年第3期610-613,共4页 Journal of Biomedical Engineering
基金 国家863计划课题资助(2002AA302209)
关键词 纳米生物技术 基因治疗 载体 生物材料 纳米粒 壳聚糖 Gene therapy Nanobiotechnology Nanobiomaterial Vector Gene delivery
  • 相关文献

参考文献22

  • 1Kohn DB. Sadelain M, Glorioso JC. Occurrence of leukaemia following gene therapy of X-linked SCID. Nature Review Cancer, 2003;3 : 477.
  • 2Fattal E, Vauthier C, Aynie I, et al. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. J Control Release, 1998;53(1-3):137.
  • 3Prabha S, Zhou WZ, Panyam J, et al. Size-dependency of nanopar ticle-mediated gene transfection : studies with fractionated nanoparticles. Int J Pharm, 2002;244(1-2): 105.
  • 4Almofti MR, Harashirna H, Shinohara Y,et al. Lipoplex size determines lipofection efficiency with or without serum. Mol Mernbr Biol, 2003;20(1):35.
  • 5Luo D, Woodrow-Mumford K, Beleheva N. Controlled DNA delivery systems. Pharm Res, 1999; 16(8):1300.
  • 6Reddy JA, Abburi C, Holland H, et al. Folate-targeted,cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther, 2002; 9(22) :1542.
  • 7Hood JD, Bednarski M, Frausto R, et al. Tumor regression by targeted gene therapy to the neovasculature. Science, 200;296(5577): 2404.
  • 8Park JW, Hong K, Carter P, et al. Development of antip185HER2 immunoliposomes for cancer therapy. Proc Natl Acad Sci USA, 1995; 92(5): 1327.
  • 9Xu L, Huang CC, Huang W, et al. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther, 2002;1(5): 337.
  • 10Tan PH, Manunta M, Ardjomand N, et al. Antibody targeted gene transfer to endothelium. J Gene Med, 2003 ;5(4): 311.

同被引文献71

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部